FindTrial
Sign In

Prospective dengue seroprevalence study in 5 to 10 year-old children

Prospective dengue seroprevalence study in 5 to 10 year-old children in India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2011/12/002243
Enrollment
3230
Registered
2011-12-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Sanofi Pasteur SA
Lead Sponsor
Sanofi Pasteur India Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: - Aged between 5 and 10 year-old on the day of inclusion - Healthy child as reported by the parent or legally qualified guardian - Being registered in selected study site - Provision of the informed consent form signed by at least one parent or legally qualified guardian - For children between 8 and 10 years old, provision of the assent form signed.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Percentage of participants with dengue specific IgG antibodies in serum samplesTimepoint: Day 0—

Secondary

MeasureTime frame
Prevalence of positive samples with dengue specific serotype DENV 1, 2,3 and/or 4Timepoint: Day 0;Prevalence of positive serum samples with JEV specific IgG antibodiesTimepoint: Day 0—

Countries

India

Contacts

Public ContactDr Rohit Arora

Sanofi Pasteur India Pvt. Ltd.

drrohit.arora@sanofipasteur.com91-2228278083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 11, 2026